Skip to main content
رجوع
Watch Compare

SPRUCE BIOSCIENCES, INC.

جودة البيانات: 100%
SPRB
Nasdaq Manufacturing Chemicals
KWD 63.63
▼ KWD 2.38 (-3.61%)
القيمة السوقية: 91.38 M
السعر
KWD 66.61
القيمة السوقية
91.38 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Debt/Equity of 0.10 — conservative balance sheet
Negative free cash flow of -33.33 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-419.76%
أقل من متوسط القطاع (-53.41%)
ROIC-293.65%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.10
أقل من متوسط القطاع (0.31)
Current Ratio1.54
Interest Coverage-405.70

التقييم

PE (TTM)
-2.35
أقل من متوسط القطاع (-1.48)
P/B Ratio16.97
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -2.4 -1.5
P/B 17.0 1.6
ROE % -419.8 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E 0.1 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -38.97 M
ROE -419.76% ROA -209.87%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -33.33 M
ROIC -293.65% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.10 Current Ratio 1.54
Interest Coverage -405.70 Asset Turnover 0.00
Working Capital 5.09 M Tangible Book Value 5.39 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.35 Forward P/E N/A
P/B Ratio 16.97 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -36.47%
Market Cap 91.38 M Enterprise Value 81.26 M
Per Share
EPS (Diluted TTM) -50.83 Revenue / Share 0.00
FCF / Share -24.29 OCF / Share -24.29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 85.53%
SBC-Adj. FCF -35.35 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 4.91 M 10.09 M — —
Net Income -38.97 M -53.04 M -47.92 M -46.18 M -42.29 M
EPS (Diluted) -50.83 -1.29 -1.24 -1.96 —
Gross Profit — — — — —
Operating Income -36.51 M -56.15 M -51.99 M -47.28 M -42.07 M
EBITDA — — — — —
R&D Expenses 19.52 M 46.42 M 49.43 M 35.20 M 30.70 M
SG&A Expenses — — — — —
D&A 21,000.0 46,000.0 70,000.0 74,000.0 68,000.0
Interest Expense 90,000.0 307,000.0 483,000.0 420,000.0 345,000.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 53.02 M 45.21 M 103.95 M 85.65 M 126.49 M
Total Liabilities 10.51 M 16.39 M 27.44 M 17.16 M 15.12 M
Shareholders' Equity 42.52 M 28.82 M 76.51 M 68.49 M 111.37 M
Total Debt 0.0 1.84 M 3.71 M 5.64 M 4.88 M
Cash & Equivalents 48.91 M 38.75 M 96.34 M 24.49 M 42.75 M
Current Assets 52.11 M 44.21 M 102.18 M 83.61 M 91.90 M
Current Liabilities 10.09 M 15.25 M 24.47 M 12.45 M 8.87 M